In addition, methylation of HtrA2 was strongly associated with survival in HCC patients, and hypomethylation was associated with a negative prognosis (HR = 0.566, P=0.0019) (Figure 4(d)). Here, HTRA2 is linked to hepatocellular carcinoma.